Yale launches clinical trial for drug to treat severe COVID-19 patients
from news.yale.edu Yale launches clinical trial for drug to treat severe COVID-19 patients By Brita Belli | Apr. 23rd, 2020 Yale researchers will begin a clinical trial at Yale New Haven Hospital to test the effectiveness of a drug called ibudilast (MN-166) for treating acute respiratory distress syndrome (ARDS), a life-threatening lung condition developed by some of the most seriously ill COVID-19 patients. The researchers are part of Yale’s Advanced Therapies Group, which was formed…
















